
Male Hypogonadism Global Market Report 2025
Description
Male Hypogonadism Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on male hypogonadism market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for male hypogonadism ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The male hypogonadism market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Type: Klinefelters Syndrome; Kallmann Syndrome; Pituitary Disorders; Other Types
2) By Drug Delivery: Topical Gels; Injectables; Transdermal Patches; Other Drug Deliveries
3) By Therapy: Testosterone Therapy; Gonadotropin-Releasing Hormone Therapy
Subsegments:
1) By Klinefelter's Syndrome: 47,XXY Syndrome; Other Variants
2) By Kallmann Syndrome: Isolated Kallmann Syndrome; Syndromic Kallmann Syndrome
3) By Pituitary Disorders: Hypopituitarism; Pituitary Tumors; Other Pituitary Disorders
4) By Other Types: Androgen Insensitivity Syndrome; Testicular Dysgenesis Syndrome; Genetic Mutations And Disorders
Companies Mentioned: Pfizer Inc.; Bayer AG; Eli Lilly and Company Ltd.; Endo International plc.; Merck & Co. Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on male hypogonadism market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for male hypogonadism ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The male hypogonadism market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Type: Klinefelters Syndrome; Kallmann Syndrome; Pituitary Disorders; Other Types
2) By Drug Delivery: Topical Gels; Injectables; Transdermal Patches; Other Drug Deliveries
3) By Therapy: Testosterone Therapy; Gonadotropin-Releasing Hormone Therapy
Subsegments:
1) By Klinefelter's Syndrome: 47,XXY Syndrome; Other Variants
2) By Kallmann Syndrome: Isolated Kallmann Syndrome; Syndromic Kallmann Syndrome
3) By Pituitary Disorders: Hypopituitarism; Pituitary Tumors; Other Pituitary Disorders
4) By Other Types: Androgen Insensitivity Syndrome; Testicular Dysgenesis Syndrome; Genetic Mutations And Disorders
Companies Mentioned: Pfizer Inc.; Bayer AG; Eli Lilly and Company Ltd.; Endo International plc.; Merck & Co. Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
200 Pages
- 1. Executive Summary
- 2. Male Hypogonadism Market Characteristics
- 3. Male Hypogonadism Market Trends And Strategies
- 4. Male Hypogonadism Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
- 5. Global Male Hypogonadism Growth Analysis And Strategic Analysis Framework
- 5.1. Global Male Hypogonadism PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Male Hypogonadism Market Growth Rate Analysis
- 5.4. Global Male Hypogonadism Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Male Hypogonadism Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Male Hypogonadism Total Addressable Market (TAM)
- 6. Male Hypogonadism Market Segmentation
- 6.1. Global Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Klinefelters Syndrome
- Kallmann Syndrome
- Pituitary Disorders
- Other Types
- 6.2. Global Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Topical Gels
- Injectables
- Transdermal Patches
- Other Drug Deliveries
- 6.3. Global Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Testosterone Therapy
- Gonadotropin-Releasing Hormone Therapy
- 6.4. Global Male Hypogonadism Market, Sub-Segmentation Of Klinefelter's Syndrome, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 47,XXY Syndrome
- Other Variants
- 6.5. Global Male Hypogonadism Market, Sub-Segmentation Of Kallmann Syndrome, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Isolated Kallmann Syndrome
- Syndromic Kallmann Syndrome
- 6.6. Global Male Hypogonadism Market, Sub-Segmentation Of Pituitary Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hypopituitarism
- Pituitary Tumors
- Other Pituitary Disorders
- 6.7. Global Male Hypogonadism Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Androgen Insensitivity Syndrome
- Testicular Dysgenesis Syndrome
- Genetic Mutations And Disorders
- 7. Male Hypogonadism Market Regional And Country Analysis
- 7.1. Global Male Hypogonadism Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Male Hypogonadism Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Male Hypogonadism Market
- 8.1. Asia-Pacific Male Hypogonadism Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Male Hypogonadism Market
- 9.1. China Male Hypogonadism Market Overview
- 9.2. China Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Male Hypogonadism Market
- 10.1. India Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Male Hypogonadism Market
- 11.1. Japan Male Hypogonadism Market Overview
- 11.2. Japan Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Male Hypogonadism Market
- 12.1. Australia Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Male Hypogonadism Market
- 13.1. Indonesia Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Male Hypogonadism Market
- 14.1. South Korea Male Hypogonadism Market Overview
- 14.2. South Korea Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Male Hypogonadism Market
- 15.1. Western Europe Male Hypogonadism Market Overview
- 15.2. Western Europe Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Male Hypogonadism Market
- 16.1. UK Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Male Hypogonadism Market
- 17.1. Germany Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Male Hypogonadism Market
- 18.1. France Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Male Hypogonadism Market
- 19.1. Italy Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Male Hypogonadism Market
- 20.1. Spain Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Male Hypogonadism Market
- 21.1. Eastern Europe Male Hypogonadism Market Overview
- 21.2. Eastern Europe Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Male Hypogonadism Market
- 22.1. Russia Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Male Hypogonadism Market
- 23.1. North America Male Hypogonadism Market Overview
- 23.2. North America Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Male Hypogonadism Market
- 24.1. USA Male Hypogonadism Market Overview
- 24.2. USA Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Male Hypogonadism Market
- 25.1. Canada Male Hypogonadism Market Overview
- 25.2. Canada Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Male Hypogonadism Market
- 26.1. South America Male Hypogonadism Market Overview
- 26.2. South America Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Male Hypogonadism Market
- 27.1. Brazil Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Male Hypogonadism Market
- 28.1. Middle East Male Hypogonadism Market Overview
- 28.2. Middle East Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Male Hypogonadism Market
- 29.1. Africa Male Hypogonadism Market Overview
- 29.2. Africa Male Hypogonadism Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Male Hypogonadism Market, Segmentation By Drug Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Male Hypogonadism Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Male Hypogonadism Market Competitive Landscape And Company Profiles
- 30.1. Male Hypogonadism Market Competitive Landscape
- 30.2. Male Hypogonadism Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Eli Lilly and Company Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Endo International plc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 31. Male Hypogonadism Market Other Major And Innovative Companies
- 31.1. Ferring Pharmaceuticals
- 31.2. Finox Biotech AG
- 31.3. Teva Pharmaceutical Industries Ltd.
- 31.4. AbbVie Inc.
- 31.5. Perrigo Company plc
- 31.6. IBSA Institut Biochimique SA
- 31.7. Sun Pharmaceutical Industries Limited
- 31.8. Glenmark Pharmaceuticals Limited
- 31.9. Antares Pharma Inc.
- 31.10. Zydus Cadila LLC
- 31.11. Besins Healthcare Ltd.
- 31.12. Clarus Therapeutics Holdings Inc.
- 31.13. Foresee Pharmaceuticals Co. Ltd.
- 31.14. Lipocine Inc.
- 31.15. Myovant Sciences Ltd.
- 32. Global Male Hypogonadism Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Male Hypogonadism Market
- 34. Recent Developments In The Male Hypogonadism Market
- 35. Male Hypogonadism Market High Potential Countries, Segments and Strategies
- 35.1 Male Hypogonadism Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Male Hypogonadism Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Male Hypogonadism Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.